ERBB2 and breast cancer: Moreover, the overexpression of human epidermal growth factor receptor-2 (ErbB-2/HER-2), which is associated with poor survival in several human malignancies including breast cancers, is closely correlated with increased angiogenesis and expression of VEGF (reviewed in Kumar and Yarmand-Bagheri, 2001).